Heart rate variability and dispersion of QT interval in patients with vulnerability to ventricular tachycardia and ventricular fibrillation after previous myocardial infarction

Journal of the American College of Cardiology

Volumn 30, Issue 5, 1997, Pages 1331-1338

  Perkiömäki, Juha S ^a   Huikuri, Heikki V ^a   Koistinen, Juhani M ^a   Mäkikallio, Timo ^a   Castellanos, Agustin ^b   Myerburg, Robert J ^b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISPERSION; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HEART RATE VARIABILITY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL;

AGED; CORONARY ANGIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ROC CURVE; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 0343907181     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00301-X     Document Type: Article

References (45)

1. Day CP, McComb JM, Campbell RWF. QT dispersion an indication of arrhythmia risk in patients with long QT intervals . Br Heart J. 63:1990;342-344.
2. Day CP, McComb JM, Campbell RWF. QT dispersion in sinus beats and ventricular extrasystoles in normal hearts. Br Heart J. 67:1992;39-41.
3. Dritsas A, Gilligan D, Nichoyannopoulos P, Oakley CM. Amiodarone reduces QT dispersion in patients with hypertrophic cardiomyopathy. Int J Cardiol. 36:1992;345-349.
4. Cowan JC, Yusoff K, Moore M, et al. Importance of lead selection in QT interval measurement. Am J Cardiol. 61:1988;83-87.
5. Day CP, McComb JM, Matthews J, Campbell RWF. Reduction in QT dispersion by sotalol following myocardial infarction. Eur Heart J. 12:1991;423-427.
6. Zabel M, Portnoy S, Franz MR. Electrocardiographic indexes of dispersion of ventricular repolarization an isolated heart validation study . J Am Coll Cardiol. 25:1995;746-752.
7. Kuo C-S, Atarashi H, Reddy CP, Surawicz B. Dispersion of ventricular repolarization and arrhythmia study of two consecutive ventricular premature complexes . Circulation. 72:1985;370-376.
8. Mitchell L, Wyse D, Duff H. Programmed electrical stimulation for ventricular tachycardia induction in humans. I. The role of ventricular functional refractoriness in tachycardia induction. J Am Coll Cardiol. 8:1986;567-575.
9. Downar E, Harris L, Mickelborough L, Shaikh N, Parson I. Endocardial mapping of ventricular tachycardia in the intact human ventricle evidence for reentrant mechanisms . J Am Coll Cardiol. 11:1988;783-791.
10. Perkiömäki J, Koistinen MJ, Yli-Mäyry S, Huikuri HV. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol. 26:1995;174-179.
11. Valkama JO, Huikuri HV, Koistinen MJ, Yli-Mäyry S, Airaksinen KEJ, Myerburg RJ. Relation between heart rate variability and spontaneous and induced ventricular arrhythmias in patients with coronary artery disease. J Am Coll Cardiol. 25:1995;437-443.
12. Huikuri HV, Koistinen MJ, Yli-Mäyry S, Airaksinen KEJ, Myerburg RJ. Impaired low frequency oscillation of heart rate in patients with prior acute myocardial infarction and life-threatening arrhythmias. Am J Cardiol. 76:1995;56-60.
13. Farrel TG, Bashir Y, Crippis T, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal averaged electrocardiogram. J Am Coll Cardiol. 18:1991;687-697.
14. Bigger JT, Fleiss JL, Steiman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart rate period variability and mortality after myocardial infarction. Circulation. 85:1992;164-172.
15. Huikuri HV, Cox M, Interian A, et al. Efficacy of intravenous propranolol for suppression of inducibility of ventricular tachyarrhythmias with different electrophysiologic characteristics in coronary artery disease. Am J Cardiol. 64:1989;1305-1309.
16. Huikuri HV, Valkama JO, Airaksinen KEJ, et al. Frequency domain measures of heart rate variability before the onset of nonsustained and sustained ventricular tachycardia in patients with coronary artery disease. Circulation. 87:1993;1220-1228.
17. Huikuri HV, Niemelä MJ, Ojala S, Rantala A, Ikäheimo MJ, Airaksinen KEJ. Circadian rhythms of frequency domain measures of heart rate variability in healthy subjects and patients with coronary artery disease effects of arousal and upright posture . Circulation. 90:1994;121-126.
18. Huikuri HV, Seppänen T, Koistinen MJ, et al. Abnormalities in beat-to-beat dynamics of heart rate before the spontaneous onset of life-threatening ventricular tachyarrhythmias in patients with prior myocardial infarction. Circulation. 93:1996;1836-1844.
19. Kairisto V, Poola A. Software for illustrative presentation of basic clinical characteristics of laboratory tests - GraphROC for Windows. Scand J Clin Lab Invest. 55:(Suppl 222):1995;43-60.
20. Zareba W, Moss AJ, le Cessie S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol. 74:1994;550-553.
21. Higham PD, Furniss SS, Campbell RWF. QT dispersion and components of the QT interval in ischaemia and infarction. Br Heart J. 73:1995;32-36.
22. Glancy JM, Garratt CJ, Woods KL, de Bono DP. QT dispersion and mortality after myocardial infarction. Lancet. 345:1995;945-948.
23. Hartikainen JEK, Malik M, Staunton A, Poloniecki J, Camm AJ. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction. J Am Coll Cardiol. 28:1996;296-304.
24. Lindsay BD, Ambos HD, Schechtman KB, Arthur RM, Cain ME. Noninvasive detection of patients with ischemic and nonischemic heart disease prone to ventricular fibrillation. J Am Coll Cardiol. 16:1990;1656-1664.
25. Stevenson WG, Brugada P, Waldecker B, Zehender M, Wellens HJJ. Clinical, angiographic, and electrophysiologic findings in patients with aborted sudden death as compared with patients with sustained ventricular tachycardia after myocardial infarction. Circulation. 71:1985;1146-1152.
26. Brugada P, Talajic M, Smeets J, Mulleneers R, Wellens HJJ. The value of the clinical history to assess prognosis of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction. Eur Heart J. 10:1989;747-752.
27. Saxon LA, Uretz EF, Denes P. Significance of the clinical presentation in ventricular tachycardia/fibrillation. Am Heart J. 118:1989;695-701.
28. Sarter BH, Finkle JK, Gerszten RE, Buxton AE. What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction? J Am Coll Cardiol. 28:1996;122-129.
29. Farrell TG, Paul V, Crippis TR, et al. Baroreflex sensitivity and electrophysiological correlates in patients after acute myocardial infarction. Circulation. 83:1991;945-952.
30. Brouwer J, van Veldhuisen DJ, Man in 't Veld AJ, et al. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. J Am Coll Cardiol. 28:1996;1183-1189.
31. Copie X, Hnatkova K, Staunton A, Fei L, Camm AJ, Malik M. Comparison of the predictive power of increased heart rate with that of depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction results of a 2-year follow-up study . J Am Coll Cardiol. 27:1996;270-276.
32. Niemelä MJ, Airaksinen KEJ, Huikuri HV. Effect of beta-blockade on heart rate variability in patients with coronary artery disease. J Am Coll Cardiol. 23:1994;1370-1377.
33. Josephson ME, Horowitz LN, Farshidi A, Kastor JA. Recurrent sustained ventricular tachycardia 1 . Mechanisms. Circulation. 57:1978;431-440.
34. Josephson ME, Horowitz LN, Farshidi A, Spear JA, Kastor JA, Moore EN. Recurrent sustained ventricular tachycardia 2 . Endocardial mapping. Circulation. 57:1978;440-447.
35. Josephson ME, Horowitz LN, Farshidi A. Continuous local electrical activity a mechanism of recurrent ventricular tachycardia . Circulation. 57:1978;660-665.
36. Horowitz LN, Josephson ME, Harken AH. Epicardial and endocardial activation during sustained ventricular tachycardia in man. Circulation. 60:1980;1227-1238.
37. deBakker JMT, van Capelle FJL, Janse MJ, et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease electrophysiologic and anatomic correlation . Circulation. 77:1988;589-606.
38. Kuo CS, Munakata K, Reddy CP, Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation. 67:1983;1356-1367.
39. Kuo CS, Amlie JP, Munakata K, Reddy CP, Surawicz B. Dispersion of monophasic action potential durations and activation times during atrial pacing, ventricular pacing, and ventricular premature stimulation in canine ventricles. Cardiovasc Res. 17:1983;152-161.
40. Kuo CS, Reddy CP, Munakata K, Surawicz B. Mechanism of ventricular arrhythmias caused by increased dispersion of repolarization. Eur Heart J. 6:1985;63-70.
41. Vaitkus PT, Kindwall KE, Marchlinski FE, Miller JM, Buxton AE, Josephson ME. Differences in electrophysiological substrate in patients with coronary artery disease and cardiac arrest or ventricular tachycardia insights from endocardial mapping and signal-averaged electrocardiography . Circulation. 84:1991;672-678.
42. Kimura S, Bassett AL, Cameron JS, Huikuri H, Kozlovskis PL, Myerburg RJ. Cellular electrophysiological changes during ischemia in isolated, coronary-perfused cat ventricle with healed myocardial infarction. Circulation. 78:1988;401-406.
43. Kimura S, Bassett AL, Kohya T, Kozlovskis PL, Myerburg RJ. Simultaneous recording of action potentials from endocardium and epicardium during ischemia in the isolated cat ventricle relation of temporal electrophysiologic heterogeneities to arrhythmias . Circulation. 74:1986;401-409.
44. Epstein AE, Carlson MD, Fogoros RN, Higgins SL, Venditti FJ. Classification of death in antiarrhythmic trials. J Am Coll Cardiol. 27:1996;433-442.
45. Pratt CM, Greenway PS, Schoenfeld MH, Hibben ML, Reiffel JA. Exploration of the precision of classifying sudden cardiac death implications for the interpretation of clinical trials . Circulation. 93:1996;519-524.